Skip to content

Ischemic Postconditioning in Cardiac Surgery

Ischemic Postconditioning in Cardiac Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01813968
Acronym
IPICS
Enrollment
209
Registered
2013-03-19
Start date
2013-01-31
Completion date
2018-06-05
Last updated
2023-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery

Keywords

Ischemic postconditioning, Adult cardiac surgery, Aortic valve surgery, Swan-Ganz, Cardiac index

Brief summary

Ischemic postconditioning by repetitive cycles of reperfusion and ischemia has been proven both in animal models and in humans. This study aims to investigate the effect of ischemic postconditioning on postoperative hemodynamic function in a standard heart surgery patient population.

Detailed description

Ischemic postconditioning is studied using cardiopulmonary bypass (CPB) and moderate hypothermia (32-34°C) in a patient population undergoing surgery of the aortic valve (repair/replacement ) or the ascending aorta. Postconditioning is applied by introducing reperfusion/ischemia via the cardioplegia line while the aorta is still cross-clamped thereby preventing the risk of additional neurological complications. All patients \> 20 years eligible for aortic or aortic valve surgery and not affected by exclusion criteria, will be included. The study is carried out as a randomised controlled multicenter study including 5-6 heart surgery centers.

Interventions

Sponsors

Medical University of Warsaw
CollaboratorOTHER
University Hospital of North Norway
CollaboratorOTHER
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
CollaboratorOTHER
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients undergoing elective surgery of the ascending aorta or the aortic valve \-

Exclusion criteria

* Coronary artery disease requiring bypass surgery * Tricuspid valve surgery * Mitral valve surgery * Atrial fibrillation (permanent or paroxysmal with or without concomitant ablation procedure) * Patients on per oral or parenteral steroid therapy (inhalational steroids are allowed) * Patients with autoimmune diseases * Redo operations * Active endocarditis (ongoing antibiotic therapy) * On the discretion of the operating surgeon or anaesthesiologist

Design outcomes

Primary

MeasureTime frameDescription
Change in cardiac index between the groups during the first postoperative dayThe first postoperative day: measurements at 2, 8 and 18 hrs postoperativelyCardiac index is measured by a Swan-Ganz catheter inserted preoperatively

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026